XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Note 14 - Equity Incentive Plan and Stock Based Compensation
6 Months Ended
May 31, 2021
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
 
14
)
Equity Incentive Plan and Stock Based Compensation
 
On
February 25, 2020,
the Board of Directors of the Company (the “Board”) authorized and approved the Art's-Way Manufacturing Co., Inc.
2020
Equity Incentive Plan (the
“2020
Plan”). The
2020
Plan was approved by the stockholders on
April 30, 2020.
The
2020
Plan replaced the Art's-Way Manufacturing Co., Inc.
2011
Equity Incentive Plan (the
“2011
Plan”) and added an additional
500,000
shares to the number of shares reserved for issuance pursuant to equity awards.
No
further awards will be made under the
2011
Plan or other prior plans. Awards to directors and executive officers under the
2020
Plan are governed by the forms of agreement approved by the Board of Directors. Stock options or other awards granted prior to
February 25, 2020,
are governed by the applicable prior plan and the forms of agreement adopted thereunder.
 
The
2020
Plan permits the plan administrator to award nonqualified stock options, incentive stock options, restricted stock awards, restricted stock units, performance awards, and stock appreciation rights to employees (including officers), directors, and consultants. The Board has approved a director compensation policy pursuant to which non-employee directors are automatically granted restricted stock awards of
1,000
shares of fully vested common stock annually or initially upon their election to the Board and another
1,000
shares of fully vested common stock on the last business day of each fiscal quarter. During the
six
months ended
May 31, 2020,
restricted stock awards of
88,500
shares were issued to various employees, directors, and consultants, which vest over the next
three
years, and restricted stock awards of
15,000
shares were issued to directors as part of the director compensation policy, which vested immediately upon grant. In comparison, during the
first
six
months of fiscal
2020,
restricted stock awards of
128,750
shares were issued to various employees, directors, and consultants, which vest over
three
years from the date of issuance, and restricted stock awards of
15,000
were issued to directors as part of the director compensation policy.
 
Stock-based compensation expense reflects the fair value of stock-based awards measured at the grant date and recognized over the relevant vesting period. The Company estimates the fair value of each stock-based option award on the measurement date using the Black-Scholes option valuation model which incorporates assumptions as to stock price volatility, the expected life of the options, risk-free interest rate, and dividend yield. Expected volatility is based on historical volatility of the Company's stock and other factors. The Company uses historical option exercise and termination data to estimate the expected term the options are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The expected dividend yield is calculated using historical dividend amounts and the stock price at the option issuance date.
No
stock options were granted during the
six
months ended
May 31, 2021,
or in the same respective period of fiscal
2020.
The Company incurred a total of
$79,745
and
$141,799
of stock-based compensation expense for restricted stock awards during the
three
and
six
months ended
May 31, 2021,
respectively, compared to
$115,172
and
$152,752
of stock-based compensation expense for restricted stock awards for the same respective periods of fiscal
2020.
The Company repurchased
3,865
shares and
9,435
shares from employees in the form of treasury stock as consideration for payroll taxes paid on the employee's behalf for the
three
and
six
months ended
May 31, 2021,
respectively, compared to
3,954
and
14,471
for the same periods in fiscal
2020.
Stock compensation net of treasury shares repurchased for the
six
months ended
May 31, 2021,
was
$111,328
compared to
$126,216
for the same period in fiscal
2020.